A B S T R A C T Chemical modification of lysine residues by acetoacetylation of the apoproteins of iodinated canine and human low density lipoproteins (LDL) and canine high density lipoproteins (HDL) resulted in a marked acceleration in the rate of removal of these lipoproteins from the plasma after intravenous injection into dogs. Clearance of the lipoproteins from the plasma correlated with their rapid appearance in the liver. Acetoacetylated canine 1251-LDL (30-60% of the lysine residues modified) were essentially completely removed from the plasma within an hour, and >75% of the activity cleared within 5 min. Reversal of the acetoacetylation of the lysine residues of the LDL restored to these lipoproteins a rate of clearance essentially identical to that of control LDL. Identical results were obtained with modified human LDL injected into dogs. At 10 min, when -90% of the acetoacetylated human 1251-LDL had been removed from the plasma, 90% of the total injected activity could be accounted for in the liver. Furthermore, it was possible to demonstrate an enhancement in uptake and degradation of acetoacetylated LDL by canine peritoneal macrophages in vitro. The mechanism(s) responsible for the enhanced removal of the LDL and HDL in vivo and in vitro remains to be determined. By contrast, however, acetoacetylation of canine 1251_ apoE HDLC did not accelerate their rate of removal from the plasma but, in fact, retarded their clearance. Control (native) apoE HDLC were removed from the plasma (64% within 20 min) and rapidly appeared in the liver (39% at 20 min). At the same time point, only 45% of the acetoacetylated apoE HDLC were cleared from the plasma and < 10% appeared in the liver.
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INTRODUCTION
Plasma lipoproteins that contain the B or E apoproteins have been shown to bind to the same low density lipoprotein (LDL)l receptors on the surface of human fibroblasts (1, 2) . High density lipoproteins (HDL), which lack the B and E apoproteins, do not bind to these receptors (1, 2) . It has been speculated that the E apoprotein of HDL, and HDLC (lipoproteins that bind to the receptors) and the B apoprotein of LDL may have a common structural sequence responisible for their interaction with the receptors (1) . Furthermore, it has been shown that modification of lysine or arginine residues of LDL and HDLC abolished their ability to react with the receptors (3, 4) . This study was designed to determine if selective modification of lysine residues by acetoacetylation would alter the in vivo catabolism of plasma lipoproteins.
Dogs were used for these lipoprotein metabolism studies (5, 6 (6) . Canine HDL (d = 1.087-1.21), similar to human HDL3, contain primarily the A-I apoprotein and only small amounts of other proteins (A-II and C apoproteins). Therefore, it was possible to compare in vivo the effects of lysine modification on lipoproteins that contain primarily the B (LDL), E (HDLC), or A-I (HDL) apoproteins.
METHODS
Lipoproteins. Normal canine LDL (d = 1.02-1.063) were isolated by ultracentrifugation from the plasma of fasted NIH foxhounds and purified by Geon-Pevikon block electrophoresis (5). Normal canine HDL (d = 1.087-1.21) were isolated by ultracentrifugation at 59,000 rpm (60 Ti rotor) for 36 h and recentrifuged at d = 1.21 for 24 h. ApoE HDLC (d = 1.006-1.02) were isolated and purified from the plasma of dogs fed diets containing coconut oil and cholesterol, as described (6) . Human LDL (d = 1.02-1.05) and HDL3 (d = 1.125-1.21) from a normal fasted subject were isolated as described (2) . Canine albumin was isolated from serum by block electrophoresis (5). All lipoproteins were isolated and used in the in vivo and in vitro studies within 2 wk after the blood was obtained. We have determined that the binding activities of canine and human LDL and canine HDLC with human fibroblasts were unaltered by storage for up to 3 wk after isolation. Untreated (native) and modified lipoproteins within an individual experiment represented separate aliquots of the same batch of lipoproteins prepared in parallel. Therefore, within an individual experiment, the lipoproteins used were the same age and represented the same lipoprotein except for the modification or lack of modification. Canine LDL, HDL, and albumin and human LDL and HDL3 were iodinated (1251) by the iodine monochloride method (7) and HDLC (125I and 1311) by the Bolton and Hunter (8) (3) . Reversal of the acetoacetylation was accomplished by incubating the modified lipoproteins with 0.5 M hydroxylamine for 16h, as described elsewhere (3) . lodinated LDL and albumin were carbamylated with potassium cyanate as described (3) . The extent of lysine modification was determined by the trinitrobenzenesulfonic acid colorimetric assay (9) and by amino acid analysis (3) . The colorimetric assay gave values 7% higher than amino acid analysis, and results are reported on the basis of amino acid analysis. Control and modified lipoproteins were characterized by paper electrophoresis, apoprotein content by gel electrophoresis, and particle morphology by negative-staining electron microscopy (3, 5) .
In vivo studies. lodinated lipoproteins or albumin (0.4-1.0 mg ofprotein) were injected into the cephalic vein of 15-20 kg male NIH foxhounds fed a normal dog chow. For specific studies, hypercholesterolemia was produced by feeding the semisynthetic coconut oil and cholesterol diet to foxhounds as described (6) . Blood samples were obtained from the jugular vein at the designated times. Liver biopsies (thin slices of <200 mg) were removed from pentobarbital-anesthetized dogs through an abdominal incision from two different sites at the designated times. Bleeding was stopped by the use of Gelfoam (Upjohn Co., Kalamazoo, Mich.). The slices of liver (1-2 mm in thickness) were washed in saline to remove blood, blotted, weighed, digested in Protosol, and counted. The total weight of the liver was determined by weighing the liver of the dog at the termination of the study after excess blood had been drained from the organ. Plasma levels were based on plasma volume of 4.5% (body weight). This was validated in several dogs by using Evans blue dye to determine plasma volume.
Canine peritoneal macrophages. The method for production and isolation of peritoneal macrophages was modified from Stephenson and Osterman (10) . Male foxhounds (15) (16) (17) (18) (19) (20) kg) were injected with 100 ml i.p. of sterile light mineral oil (Barre Drug Co., Baltimore, Md.). After 7 d, 1 liter of sterile saline was infused into the peritoneal cavity of the anesthetized dogs, and then the fluid was removed with a stylocath (Abbott Diagnostics, North Chicago, Ill.). The cells were pelleted by centrifugation at 160 g for 5 min and then resuspended at 1 x 107 cells/ml in Dulbecco's modified Eagle medium containing 20% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 gg/ml). Cells (2 ml) were dispensed into 35-mm Petri dishes and allowed to settle for 2 h in a humidified (5-8% C02) incubator at 37°C. They were then washed twice with Hanks' base salt solution (GIBCO catalogue No. 310-4020, Grand Island Biological, Grand Island, N. Y.) and incubated with Dulbecco's modified Eagle medium and 20% fetal calf serum until the experiment was performed 16-20 h later. In contrast to polymorphonuclear leukocytes, macrophages rapidly become adherent to the dishes. By light and phase microscopy, the adherent cells were large, flat, motile cells, characteristic of' macrophages (11), which contained translucent intracellular vacuoles, presumably ingested oil.
In vitro assays. Assays for binding and internalization and degradation were performed on the macrophages for 6 h (37°C) as reported for fibroblasts (2) , except that the incubation media (1 ml/dish) contained 20% fetal calf serum. Each dish contained -0.1 mg of cell protein.
RESULTS
Acetoacetylation of -30-60% of the lysine residues of canine and human '251-LDL resulted in a markedly accelerated clearance of these lipoproteins from the plasma of the dog after intravenous injection. As shown in Fig. 1 and Table I for representative experiments, >75% of the acetoacetylated canine LDL were removed from the plasma within 5 min after injection. The activity did not reappear in the plasma (Fig. 1 Table I , document the consistent finding that acetoacetylation of >30% of the lysine residues accelerated the clearance of LDL from the plasma. These data were obtained in individual animals.
Before injection, 97% of the radioactivity of the control canine LDL and acetoacetylated LDL was precipitable with TCA, and >98% of the radioactivity associated with the LDL was in the B apoprotein as determined by tetramethylurea precipitation. 1 h after injection of the control LDL, the lipoproteins that remained in the plasma were reisolated and characterized. Greater than 90% of the activity that remained floated by ultracentrifugation at d < 1.21 and 95% was associated with the B apoprotein. With the acetoacetylated LDL, only 13% of the total injected activity remained in the plasma at 1 h, and of that only 1% floated at d < 1.21. The remainder was found in the d > 1.21 fraction, and essentially all of that activity was represented by low molecular weight material, which passed through a dialysis membrane. The dialyzable material was not further characterized but, as shown later, degradation products ('251-tyrosine) rapidly appeared in the plasma of animals receiving acetoacetylated LDL. The acetoacetylated LDL, therefore, were rapidly and almost completely cleared from the plasma in <1 h.
When modified human '251-LDL were injected into dogs, accelerated removal of these lipoproteins was also observed. As shown in Fig. 2 , -90% of the acetoacetylated human LDL (48% of the lysine residues modified) were removed from the plasma and 90% of the total injected dose could be accounted for in the liver within 10 min. At the same time point, 81 and 8% of the total control LDL were in the plasma and liver, respectively. Acetoacetylation of 20% of the lysine 4 32% of total injected activity in the liver. § Greater than 50% of the total lysine residues modified. Level ofmodification was not measured but expected level would be 30-40% ofthe lysine residues modified, as described (3). ¶ 22% of total lysine residues modified. residues of human 1251-LDL did not significantly alter their removal rate. The nearly quantitative hepatic uptake of acetoacetylated human and rat LDL (30-60% of the lysine residues modified) has been documented by studies in rats. Furthermore, the activity in the livers of the rats has been localized by autoradiography in the Kupffer cells.2 Modification of lysine residues of canine LDL and canine albumin by carbamylation also resulted in their accelerated clearance from the plasma (Table I) . Likewise, canine HDL (d = 1.087-1.21) removal from the plasma was accelerated after acetoacetylation of 78% of the lysine residues (Table I ), but the removal rate for HDL was unaltered when <40% of the lysine residues were modified. Acetoacetylation of human HDL3 (d = 1.125-1.21) also resulted in an accelerated disappearance from the plasma (Table I) .
Because the accelerated hepatic removal of modified LDL appeared to be mediated by the Kupffer cells, studies were undertaken to determine if enhanced uptake would occur in peritoneal macrophages maintained in culture. Macrophages were shown to bind and internalize (Fig. 3A) and degrade (Fig. 3B) of the lysine residues modified, and acetoacetylated (56%)-reversed (<1% of the residues remained modified) 1251-LDL (x) were compared directly in assays performed at 37°C.
blasts. However, acetoacetylation of the LDL increased the amount of lipoprotein bound and degraded (Figs. 3 and 4). The most dramatic effects (an 8-to 10-fold enhancement) were seen with an LDL preparation that had 73% of the lysine residues modified (Fig. 4) . Modified LDL that had been incubated with hydroxylamine to reverse the acetoacetylation of the lysine residues gave results identical to those of the control LDL (Fig.  3 ). This further indicated that the acetoacetylation had not irreversibly altered the LDL. All the acetoacetylated LDL used in the studies with the macrophages were incapable of binding to the high affinity cell receptors of human fibroblasts. It has previously been reported that acetoacetylated LDL (>20% of the lysine residues modified) were not bound and degraded by fibroblasts (3). In striking contrast to the accelerated rate of removal of acetoacetylated canine and human LDL and canine HDL from the plasma, canine apoE HDLe modified to a similar extent (30-60% ofthe lysine residues modified) were cleared from the plasma much more slowly than the unmodified (control) HDLC (Fig. 5) . Control apoE HDLC were normally removed from the plasma more rapidly than LDL (Fig. 1) . The acute phase of the removal of control HDLC could be accounted for by a rapid hepatic uptake (Fig. 5) . By 20 min after the injection, 64% of the control HDLC had been cleared from the plasma and 39% of the total injected dose could be accounted for in the liver. However, after FIGURE 5 Percentage of the total injected dose of control 1251-apoE HDL (0) and acetoacetylated '251-apoE HDLC (A, 60% of the lysine residues modified) that remained in the plasma with time in hours (A) and that appeared in the liver in minutes (B). Additional data from two separate dogs which received either control '251-apoE HDLC (0) or acetoacetylated 1251-apoE HDL (A). The activity in the liver was calculated on the basis of the actual weight of the liver. Values acetoacetylation, HDLC removal was markedly retarded (Fig. 5) , and at several time points after injection, 10% of the total activity was present in the liver. These results suggested that a large fraction of the apoE HDL was normally taken up by the liver and that lysine modification retarded the recognition and(or) removal process. These results were confirmed by the simultaneous injection of native 131I-apoE HDL and acetoacetylated 1251-apoE HDLC into the same normolipidemic dog and by the measurement of the disappearance of both isotopes from the plasma (Fig. 6A) . The unmodified and modified apoE HDLC were isolated from the same plasma and were prepared in parallel for injection.
Modifications that Alter Lipoprotein Metabolism By 5 min after injection, 56% of the native apoE HDL, and 15% of the acetoacetylated apoE HDLC had been removed from the plasma. After the rapid, acute phase of clearance, the rates of disappearance of the native and modified apoE HDL, from the plasma were similar (see Discussion).
Consideration was given to the possibility that the rapid removal of the unmodified (native) apoE HDL, could be a result of the absence of an HDLQ pool in the plasma of normal dogs. However, the rapid clearance of the unmodified 131I-apoE HDLC and the retarded clearance of the acetoacetylated '251-apoE HDL,
were similarly observed when these lipoproteins were simultaneously injected into a hypercholesterolemic dog (Fig. 6B) . Within 5 min, 50% of the native apoE HDLC had been cleared from the plasma, whereas only 20% of the acetoacetylated apoE HDL, was removed. After the initial few minutes, the rates of removal of the native and modified apoE HDLc appeared to be slower in the hypercholesterolemic dog than in the normal dog (see Discussion). The native and acetoacetylated apoE HDLc were incubated with peritoneal macrophages maintained under culture conditions. As shown in Fig. 7 for a representative experiment, control apoE HDLC were not taken up and degraded by peritoneal macrophages to a significant extent by comparison with results obtained in cultured human fibroblasts (1-3) . Moreover, acetoacetylation of HDLC, even at 64% lysine modification, did not enhance the uptake or degradation of these lipoproteins by the macrophages (Fig. 7) . We have been unable to modify >64% of the lysine residues, presumably because the other residues are inaccessible to the reagent.
DISCUSSION
Aggregated and heat or chemically denatured proteins are rapidly cleared from the plasma by the reticuloendothelial system, including Kupffer cells of the liver and other scavenger cells throughout the body. It has been suggested that modifications that increase the net negative charge on proteins may also trigger the rapid uptake of altered proteinis (11, 13, 14) . This stuidy indicates that selective modification of lysine residues without aggregation or precipitation can stimulate clearance of certain proteins (LDL, HDL, and albumin) from the plasma. For several reasons, acetoacetylation with diketene is a particularly useful procedure with which to study this process. Acetoacetylation selectively modifies the lysine residues as previously shown for both LDL and HDL,. (3) . The positive charge on the e-amino group of lysine is neutralized, and a net increase in the negativity of the lipoproteins is observed. Other physical and chemical properties of the lipoproteins including lipid and protein composition and particle size and morphology are unchanged (3) . In addition, we have not detected an alteration in the protein conformation of LDL by circular dichroism after extensive lysine modification (unpublished data); however, although it is impossible to rule out discrete changes that may occur, there are no detectable gross alterations. Furthermore, acetoacetylation of lysine residues can be quantitatively reversed, and the modified, reversed lipoproteins have been shown to regain metabolic activity very similar to that of the native lipoproteins. As reported (3), acetoacetylated LDL are incapable of binding to the cell surf:ace receptors of fibroblasts, but after the reversal of the modification, LDL regain nearly full binding activity. A similar reversibility of the rapid plasma clearance of LDL is presented here.
Rapid plasma clearance of acetoacetylated 1251. LDL (essentially complete in less than an hour) and the appearance of activity in the liver were correlated with an enhancement in uptake and degradation of these modified LDL by peritoneal macrophages. Whether or not recognition of acetoacetylated LDL by the macrophages and by the liver is mediated by a common process and whether or not the stimulus for uptake by either system is an alteration in positive charge is open to speculation. However Several tentative conclusions are suggested by the data. The observation that the unmodified apoE HDLI were rapidly removed from the plasma and appeared in the liver within minutes of injection suggests that the liver may be a normal site for clearance of apoE HDLC. The retardation in removal by acetoacetylation of the apoE HDL indicates that the E apoprotein might be involved in the hepatic removal process and that the process may be mediated by a lysine-dependent recognition system. Previously, we have demonstrated that the lysine residues of the apoE HDLC play a functional role in the interaction of these lipoproteins with the cell surface receptors of fibroblasts (3). However, it should be pointed out that after the acute phase (0-60 min after injection) the rates of clearance of the unmodified (native) and the modified apoE HDLC were similar. The most likely explanation for this is that the apoE of the HDLC redistributes with time to other lipoproteins and is no longer associated exclusively with the cholesteryl ester-rich apoE HDLC. Once redistribution occurs (the time required for this to occur to a significant extent remains unknown), then the rate of removal of the iodinated apoE from the plasma would depend upon the actual class of lipoproteins with which the label is associated. We have previously demonstrated that the apoE of various lipoproteins does redistribute after injection into rats (15) . This does not negate the significance of our observation that acetoacetylation of the E apoprotein acutely retarded the uptake of the modified apoE HDLC as compared with the more rapid uptake of the unmodified apoE HDLC. However, it is difficult to prove that the clearance of the unmodified apoE HDLC by the liver during the first few minutes was associated exclusively with the uptake of the apoE HDLC particles. Recognition and uptake by the liver might require that the lipoprotein have a critical mass of the E apoprotein, as occurs in the cholesteryl ester-rich apoE HDLC.
The similarity in the data obtained acutely in the hypercholesterolemic dog as compared to the results in a normolipidemic dog indicates that the pool size of plasma HDLC does not have a significant effect on the rapid uptake process (<1 h after injection). However, between 1 and 4 h, the overall rate of removal of both the unmodified and modified apoE HDLC was slower in the hypercholesterolemic dog than in the normal dog. This is consistent with the idea of redistribution of the apoE to a larger pool of apoE containing lipoproteins. The cholesterol-fed dog had a plasma cholesterol level of _400 mgldl and an abundance of plasma HDLC, as reported (6) . These results in the acute phase of the study support the conclusion that acetoacetylation of 30% or more of the lysine residues of apoE HDLC interferes with the hepatic removal process.
